Clinical Consultations™: Raising Awareness and Optimizing Treatment in Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID)

CME: 1.0

Target Audience

This educational activity is directed toward health care professionals who treat patients with ADA-SCID, including pediatric immunologists, bone marrow transplant physicians, pediatric infectious disease experts, nurse practitioners, physician assistants, and nurses.

Program Overview

This Clinical Consultations™ is a video-based program in which 2 experts use a case-based approach to discuss the diagnosis and management of patients with adenosine deaminase severe combined immunodeficiency (ADA-SCID). In this activity, the faculty focus on individualizing approaches to the diagnosis and treatment of patients with ADA-SCID. This engaging format is designed to help clinicians identify best practices in the diagnosis and management of ADA-SCID and to improve outcomes for their patients with this disease.

Learning Objectives

Upon completion of this activity, participants should be better able to:
  • Discuss the role of screening for infants with suspected ADA-SCID
  • Implement optimal strategies for diagnosing infants with ADA-SCID
  • Create individualized treatment plans for optimal management of patients with ADA-SCID

Post a comment to this article